Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astagold
- Development stage
- Unknown
- Lead developer
- Sunways India
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Astagold is an oral nutritional supplement developed by Sunways India to support eye health and manage vision-related conditions. It is formulated as a combination of potent antioxidants, vitamins, and minerals, including astaxanthin, lutein, zeaxanthin, vitamin A, vitamin C, vitamin E, zinc, copper, and selenium. Astagold is primarily indicated as an adjuvant therapy for the management of asthenopia (eye strain), age-related macular degeneration (ARMD), and diabetic retinopathy. The active ingredients work synergistically to protect retinal cells from oxidative stress, filter harmful blue light, and support overall visual function.
- Brand names
- AstagoldAstagold-i
- Other names
- astaxanthin + lutein + zeaxanthin + vitamin A + vitamin C + vitamin E + zinc + copper + selenium
Beyond the preview
Go deeper on Astagold.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astagold.